Allogeneic Human Chondrocyte Market, Global Outlook and Forecast 2022-2028

January 2022 | 61 pages | ID: A64D013E811DEN
Market Monitor Global

Abstracts

Allogeneic human chondrocyte is an emerging therapy that can be used for cartilage repair and other indications. Only few players are involved in the development of this treatment procedure. Allogeneic human articular chondrocytes (hAC) could be a good alternative; however, the possibility of immunological incompatibility between recipient and hAC donor should be considered.

This report contains market size and forecasts of Allogeneic Human Chondrocyte in Global, including the following market information:

Global Allogeneic Human Chondrocyte Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Allogeneic Human Chondrocyte market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hospitals Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Allogeneic Human Chondrocyte include Kolon TissueGene, Inc., ISTO Technologies Inc., Zimmer Biomet, Genzyme, CellGenix and EMD Serono, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Allogeneic Human Chondrocyte companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Allogeneic Human Chondrocyte Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Allogeneic Human Chondrocyte Market Segment Percentages, by Type, 2021 (%)

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Global Allogeneic Human Chondrocyte Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Allogeneic Human Chondrocyte Market Segment Percentages, by Application, 2021 (%)

• Osteoarthritis
• Musculoskeletal System Disorders
• Others

Global Allogeneic Human Chondrocyte Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Allogeneic Human Chondrocyte Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Allogeneic Human Chondrocyte revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Allogeneic Human Chondrocyte revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Kolon TissueGene, Inc.
• ISTO Technologies Inc.
• Zimmer Biomet
• Genzyme
• CellGenix
• EMD Serono

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Allogeneic Human Chondrocyte Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Allogeneic Human Chondrocyte Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ALLOGENEIC HUMAN CHONDROCYTE OVERALL MARKET SIZE

2.1 Global Allogeneic Human Chondrocyte Market Size: 2021 VS 2028
2.2 Global Allogeneic Human Chondrocyte Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Allogeneic Human Chondrocyte Players in Global Market
3.2 Top Global Allogeneic Human Chondrocyte Companies Ranked by Revenue
3.3 Global Allogeneic Human Chondrocyte Revenue by Companies
3.4 Top 3 and Top 5 Allogeneic Human Chondrocyte Companies in Global Market, by Revenue in 2021
3.5 Global Companies Allogeneic Human Chondrocyte Product Type
3.6 Tier 1, Tier 2 and Tier 3 Allogeneic Human Chondrocyte Players in Global Market
  3.6.1 List of Global Tier 1 Allogeneic Human Chondrocyte Companies
  3.6.2 List of Global Tier 2 and Tier 3 Allogeneic Human Chondrocyte Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Allogeneic Human Chondrocyte Market Size Markets, 2021 & 2028
  4.1.2 Hospitals
  4.1.3 Specialty Clinics
  4.1.4 Ambulatory Surgical Centers
4.2 By Type - Global Allogeneic Human Chondrocyte Revenue & Forecasts
  4.2.1 By Type - Global Allogeneic Human Chondrocyte Revenue, 2017-2022
  4.2.2 By Type - Global Allogeneic Human Chondrocyte Revenue, 2023-2028
  4.2.3 By Type - Global Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Allogeneic Human Chondrocyte Market Size, 2021 & 2028
  5.1.2 Osteoarthritis
  5.1.3 Musculoskeletal System Disorders
  5.1.4 Others
5.2 By Application - Global Allogeneic Human Chondrocyte Revenue & Forecasts
  5.2.1 By Application - Global Allogeneic Human Chondrocyte Revenue, 2017-2022
  5.2.2 By Application - Global Allogeneic Human Chondrocyte Revenue, 2023-2028
  5.2.3 By Application - Global Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Allogeneic Human Chondrocyte Market Size, 2021 & 2028
6.2 By Region - Global Allogeneic Human Chondrocyte Revenue & Forecasts
  6.2.1 By Region - Global Allogeneic Human Chondrocyte Revenue, 2017-2022
  6.2.2 By Region - Global Allogeneic Human Chondrocyte Revenue, 2023-2028
  6.2.3 By Region - Global Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Allogeneic Human Chondrocyte Revenue, 2017-2028
  6.3.2 US Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.3.3 Canada Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.3.4 Mexico Allogeneic Human Chondrocyte Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Allogeneic Human Chondrocyte Revenue, 2017-2028
  6.4.2 Germany Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.4.3 France Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.4.4 U.K. Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.4.5 Italy Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.4.6 Russia Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.4.7 Nordic Countries Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.4.8 Benelux Allogeneic Human Chondrocyte Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Allogeneic Human Chondrocyte Revenue, 2017-2028
  6.5.2 China Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.5.3 Japan Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.5.4 South Korea Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.5.5 Southeast Asia Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.5.6 India Allogeneic Human Chondrocyte Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Allogeneic Human Chondrocyte Revenue, 2017-2028
  6.6.2 Brazil Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.6.3 Argentina Allogeneic Human Chondrocyte Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Allogeneic Human Chondrocyte Revenue, 2017-2028
  6.7.2 Turkey Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.7.3 Israel Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.7.4 Saudi Arabia Allogeneic Human Chondrocyte Market Size, 2017-2028
  6.7.5 UAE Allogeneic Human Chondrocyte Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Kolon TissueGene, Inc.
  7.1.1 Kolon TissueGene, Inc. Corporate Summary
  7.1.2 Kolon TissueGene, Inc. Business Overview
  7.1.3 Kolon TissueGene, Inc. Allogeneic Human Chondrocyte Major Product Offerings
  7.1.4 Kolon TissueGene, Inc. Allogeneic Human Chondrocyte Revenue in Global Market (2017-2022)
  7.1.5 Kolon TissueGene, Inc. Key News
7.2 ISTO Technologies Inc.
  7.2.1 ISTO Technologies Inc. Corporate Summary
  7.2.2 ISTO Technologies Inc. Business Overview
  7.2.3 ISTO Technologies Inc. Allogeneic Human Chondrocyte Major Product Offerings
  7.2.4 ISTO Technologies Inc. Allogeneic Human Chondrocyte Revenue in Global Market (2017-2022)
  7.2.5 ISTO Technologies Inc. Key News
7.3 Zimmer Biomet
  7.3.1 Zimmer Biomet Corporate Summary
  7.3.2 Zimmer Biomet Business Overview
  7.3.3 Zimmer Biomet Allogeneic Human Chondrocyte Major Product Offerings
  7.3.4 Zimmer Biomet Allogeneic Human Chondrocyte Revenue in Global Market (2017-2022)
  7.3.5 Zimmer Biomet Key News
7.4 Genzyme
  7.4.1 Genzyme Corporate Summary
  7.4.2 Genzyme Business Overview
  7.4.3 Genzyme Allogeneic Human Chondrocyte Major Product Offerings
  7.4.4 Genzyme Allogeneic Human Chondrocyte Revenue in Global Market (2017-2022)
  7.4.5 Genzyme Key News
7.5 CellGenix
  7.5.1 CellGenix Corporate Summary
  7.5.2 CellGenix Business Overview
  7.5.3 CellGenix Allogeneic Human Chondrocyte Major Product Offerings
  7.5.4 CellGenix Allogeneic Human Chondrocyte Revenue in Global Market (2017-2022)
  7.5.5 CellGenix Key News
7.6 EMD Serono
  7.6.1 EMD Serono Corporate Summary
  7.6.2 EMD Serono Business Overview
  7.6.3 EMD Serono Allogeneic Human Chondrocyte Major Product Offerings
  7.6.4 EMD Serono Allogeneic Human Chondrocyte Revenue in Global Market (2017-2022)
  7.6.5 EMD Serono Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Allogeneic Human Chondrocyte Market Opportunities & Trends in Global Market
Table 2. Allogeneic Human Chondrocyte Market Drivers in Global Market
Table 3. Allogeneic Human Chondrocyte Market Restraints in Global Market
Table 4. Key Players of Allogeneic Human Chondrocyte in Global Market
Table 5. Top Allogeneic Human Chondrocyte Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Allogeneic Human Chondrocyte Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Allogeneic Human Chondrocyte Revenue Share by Companies, 2017-2022
Table 8. Global Companies Allogeneic Human Chondrocyte Product Type
Table 9. List of Global Tier 1 Allogeneic Human Chondrocyte Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Allogeneic Human Chondrocyte Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Allogeneic Human Chondrocyte Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Allogeneic Human Chondrocyte Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Allogeneic Human Chondrocyte Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Allogeneic Human Chondrocyte Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Allogeneic Human Chondrocyte Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Allogeneic Human Chondrocyte Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2023-2028
Table 30. Kolon TissueGene, Inc. Corporate Summary
Table 31. Kolon TissueGene, Inc. Allogeneic Human Chondrocyte Product Offerings
Table 32. Kolon TissueGene, Inc. Allogeneic Human Chondrocyte Revenue (US$, Mn), (2017-2022)
Table 33. ISTO Technologies Inc. Corporate Summary
Table 34. ISTO Technologies Inc. Allogeneic Human Chondrocyte Product Offerings
Table 35. ISTO Technologies Inc. Allogeneic Human Chondrocyte Revenue (US$, Mn), (2017-2022)
Table 36. Zimmer Biomet Corporate Summary
Table 37. Zimmer Biomet Allogeneic Human Chondrocyte Product Offerings
Table 38. Zimmer Biomet Allogeneic Human Chondrocyte Revenue (US$, Mn), (2017-2022)
Table 39. Genzyme Corporate Summary
Table 40. Genzyme Allogeneic Human Chondrocyte Product Offerings
Table 41. Genzyme Allogeneic Human Chondrocyte Revenue (US$, Mn), (2017-2022)
Table 42. CellGenix Corporate Summary
Table 43. CellGenix Allogeneic Human Chondrocyte Product Offerings
Table 44. CellGenix Allogeneic Human Chondrocyte Revenue (US$, Mn), (2017-2022)
Table 45. EMD Serono Corporate Summary
Table 46. EMD Serono Allogeneic Human Chondrocyte Product Offerings
Table 47. EMD Serono Allogeneic Human Chondrocyte Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Allogeneic Human Chondrocyte Segment by Type in 2021
Figure 2. Allogeneic Human Chondrocyte Segment by Application in 2021
Figure 3. Global Allogeneic Human Chondrocyte Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Allogeneic Human Chondrocyte Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Allogeneic Human Chondrocyte Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Allogeneic Human Chondrocyte Revenue in 2021
Figure 8. By Type - Global Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 9. By Application - Global Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 10. By Region - Global Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 11. By Country - North America Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 12. US Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 16. Germany Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 17. France Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 24. China Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 28. India Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 30. Brazil Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Allogeneic Human Chondrocyte Revenue Market Share, 2017-2028
Figure 33. Turkey Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Allogeneic Human Chondrocyte Revenue, (US$, Mn), 2017-2028
Figure 37. Kolon TissueGene, Inc. Allogeneic Human Chondrocyte Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ISTO Technologies Inc. Allogeneic Human Chondrocyte Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zimmer Biomet Allogeneic Human Chondrocyte Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Genzyme Allogeneic Human Chondrocyte Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. CellGenix Allogeneic Human Chondrocyte Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. EMD Serono Allogeneic Human Chondrocyte Revenue Year Over Year Growth (US$, Mn) & (2017-2022)